Ultrasound-guided Percutaneous Microwave Ablation for Benign Thyroid Nodules

W

Wenjun Wu

Status

Unknown

Conditions

Thyroid Nodule

Treatments

Device: Microwave Ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT03057925
wwju127

Details and patient eligibility

About

Percutaneous microwave ablation(MWA) was reported as an effective modality for the management of thyroid nodules(TNs). This study aims to validate MWA as a feasible approach for patients with TNs for whom surgery is contraindicated or refused. Two groups of subjects with TNs(one group to treat with MWA and the other group to receive regular ultrasonic follow-up without any treatment) will be evaluated in term of TN volume, ultrasonic image and clinical symptoms.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age>18 years
  • benign thyroid nodules(TYP 2)
  • solid or predominantly solid(colloid component<30%)large (>3.0ml) thyroid nodules
  • refusal and/or inefficacy of surgery

Exclusion criteria

  • pregnancy
  • malignant or suspicious thyroid nodules

Trial design

60 participants in 2 patient groups

Group A
Experimental group
Description:
MWA Percutaneous Microwave Ablation intervention procedure: Ultrasound-guided Percutaneous Microwave Ablation
Treatment:
Device: Microwave Ablation
Group B
No Intervention group
Description:
untreated no treatment; regular ultrasonic image follow-up

Trial contacts and locations

0

Loading...

Central trial contact

Zimiao Chen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems